Javier Aller

1.4k total citations
37 papers, 522 citations indexed

About

Javier Aller is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Javier Aller has authored 37 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 10 papers in Oncology. Recurrent topics in Javier Aller's work include Pituitary Gland Disorders and Treatments (19 papers), Adrenal and Paraganglionic Tumors (14 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Javier Aller is often cited by papers focused on Pituitary Gland Disorders and Treatments (19 papers), Adrenal and Paraganglionic Tumors (14 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Javier Aller collaborates with scholars based in Spain, United Kingdom and France. Javier Aller's co-authors include Enrique Grande, Paula Jiménez‐Fonseca, Jaume Capdevila, Rocio García‐Carbonero, Nuria Palacios, Alberto Carmona‐Bayonas, Javier Solis Estrada, Ignacio Bernabéu, Mónica Marazuela and Guillermo Crespo and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Annals of Oncology.

In The Last Decade

Javier Aller

34 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Aller Spain 15 299 244 210 141 136 37 522
Aude Houchard France 16 356 1.2× 235 1.0× 194 0.9× 172 1.2× 137 1.0× 53 587
Anouk N. van der Horst‐Schrivers Netherlands 15 133 0.4× 484 2.0× 352 1.7× 335 2.4× 82 0.6× 17 603
Martin B. Niederle Austria 8 140 0.5× 403 1.7× 331 1.6× 222 1.6× 125 0.9× 26 535
Rachel S. van Leeuwaarde Netherlands 14 99 0.3× 425 1.7× 350 1.7× 294 2.1× 61 0.4× 43 556
Laurent Tessonnier France 9 208 0.7× 104 0.4× 105 0.5× 79 0.6× 253 1.9× 23 424
Otello Daniele Italy 11 265 0.9× 253 1.0× 94 0.4× 426 3.0× 250 1.8× 19 642
Hemen K. Parikh India 8 94 0.3× 292 1.2× 68 0.3× 215 1.5× 231 1.7× 14 477
Wouter K. de Jong Netherlands 9 104 0.3× 146 0.6× 114 0.5× 218 1.5× 64 0.5× 15 446
Iraklis Vainas Greece 11 231 0.8× 89 0.4× 55 0.3× 20 0.1× 138 1.0× 18 337
Jeffrey A. Norton United States 10 103 0.3× 357 1.5× 266 1.3× 220 1.6× 125 0.9× 10 473

Countries citing papers authored by Javier Aller

Since Specialization
Citations

This map shows the geographic impact of Javier Aller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Aller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Aller more than expected).

Fields of papers citing papers by Javier Aller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Aller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Aller. The network helps show where Javier Aller may publish in the future.

Co-authorship network of co-authors of Javier Aller

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Aller. A scholar is included among the top collaborators of Javier Aller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Aller. Javier Aller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araujo‐Castro, Marta, Javier Aller, Mónica Marazuela, et al.. (2025). Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinología Diabetes y Nutrición. 72(10). 501654–501654. 1 indexed citations
2.
Puig‐Domingo, Manel, Ignacio Bernabéu, Antonio Picó, et al.. (2021). Pasireotide in the Personalized Treatment of Acromegaly. Frontiers in Endocrinology. 12. 648411–648411. 29 indexed citations
3.
Cámara, Rosa, Eva Venegas, Juan Antonio García-Arnés, et al.. (2019). Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study. Pituitary. 22(2). 137–145. 9 indexed citations
4.
Sánchez-Cenizo, Laura, et al.. (2019). <p>Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain</p>. ClinicoEconomics and Outcomes Research. Volume 11. 465–475.
5.
Grande, Enrique, Carlos López, Ruth Vera, et al.. (2019). Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review. Therapeutic Advances in Endocrinology and Metabolism. 10. 2388748793–2388748793. 8 indexed citations
6.
Barriuso, Jorge, Ana Custodio, Vicente Alonso, et al.. (2018). Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours. Cancer Treatment Reviews. 70. 209–222. 13 indexed citations
7.
Bernabéu, Ignacio, et al.. (2018). Criterios para el diagnóstico y el control poscirugía de la acromegalia, y el cribado y el manejo de sus comorbilidades: recomendaciones de expertos. Endocrinología Diabetes y Nutrición. 65(5). 297–305. 8 indexed citations
8.
Capdevila, Jaume, Kate Newbold, Lisa Licitra, et al.. (2018). Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer. Cancer Treatment Reviews. 69. 164–176. 35 indexed citations
9.
Araujo‐Castro, Marta, et al.. (2018). Ectopic Cushing syndrome: Report of 9 cases. Endocrinología Diabetes y Nutrición (English ed ). 65(5). 255–264. 7 indexed citations
10.
Merino, Xavier, Javier Aller, Javier Arbizu, et al.. (2018). Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors. Clinical & Translational Oncology. 20(12). 1522–1528. 14 indexed citations
11.
12.
Capdevila, Jaume, Oriol Casanovas, Ramón Salazar, et al.. (2016). Translational research in neuroendocrine tumors: pitfalls and opportunities. Oncogene. 36(14). 1899–1907. 24 indexed citations
13.
Bernabéu, Ignacio, Antonio Picó, Eva Venegas, et al.. (2015). Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY. Pituitary. 19(2). 127–137. 20 indexed citations
14.
Jiménez‐Fonseca, Paula, Alberto Carmona‐Bayonas, Elena Martín‐Pérez, et al.. (2015). Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer and Metastasis Reviews. 34(3). 381–400. 45 indexed citations
15.
Palacios, Nuria, et al.. (2015). Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment. Pituitary. 19(2). 158–166. 24 indexed citations
16.
Sesmilo, Gemma, Eugenia Resmini, Ignacio Bernabéu, et al.. (2014). Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre S panish study. Clinical Endocrinology. 81(6). 883–890. 17 indexed citations
17.
Salas, Clara, et al.. (2013). Carta científicaFeocromocitoma productor de corticotropinaAdrenocorticotropic-secreting pheochromocytoma. Endocrinología y Nutrición. 60(7). 1 indexed citations
18.
Rodríguez‐Antona, Cristina, Lucía Inglada‐Pérez, Aguirre A. de Cubas, et al.. (2013). Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma. Endocrine Related Cancer. 20(4). 611–619. 17 indexed citations
19.
Valderrábano, Pablo, et al.. (2013). Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up. Endocrinología y Nutrición. 61(4). 176–183. 34 indexed citations
20.
Valdés, Nuria, et al.. (1999). Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop). Clinical Endocrinology. 50(3). 309–313. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aude Houchard Breakdown of academic impact, for papers by Anouk N. van der Horst‐Schrivers Breakdown of academic impact, for papers by Martin B. Niederle Breakdown of academic impact, for papers by Rachel S. van Leeuwaarde Breakdown of academic impact, for papers by Laurent Tessonnier Breakdown of academic impact, for papers by Otello Daniele Breakdown of academic impact, for papers by Hemen K. Parikh Breakdown of academic impact, for papers by Wouter K. de Jong Breakdown of academic impact, for papers by Iraklis Vainas Breakdown of academic impact, for papers by Jeffrey A. Norton
Rankless by CCL
2026